Submitted by Anonymous (not verified) on 8 October 2026 - 16:25
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised